GARDASIL 9
9-valent HPV L1 protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58) · HPV
Health Canada DIN 02437058. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- GARDASIL 9
- DIN
02437058- Vaccine
- 9-valent HPV L1 protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Presentation
- 0.5 mL · suspension · intramuscular · 9 to 45 years
- Live vaccine
- No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| HPV — ages 9 to 20, one dose One dose of 9-valent HPV vaccine for people who start at age 9 through 20. | 1 dose | Age at the first dose decides the schedule. A 2-dose schedule may be considered on an individual basis. People who are immunocompromised or living with HIV need three doses. |
| HPV — ages 9 to 20, optional two doses Optional two-dose schedule, at least 24 weeks apart. | 2 doses | May be considered individually for people who start at age 9 through 20, after discussion with a healthcare provider. The two doses must be at least 24 weeks apart. |
| HPV — ages 21 to 26, two doses Two doses of 9-valent HPV vaccine at least 24 weeks apart. | 2 doses | Recommended for people 21 through 26 years of age: two doses at least 24 weeks (6 months) apart. |
| HPV — age 27 and older, two doses after a shared decision Two doses at least 24 weeks apart, decided with a healthcare provider. | 2 doses | At 27 years and older, HPV vaccination is a shared decision with a healthcare provider (GARDASIL 9 is authorized to 45 years). When given: two doses at least 24 weeks apart. |
| HPV — weakened immune system or HIV, three doses Three doses of 9-valent HPV vaccine at months 0, 2 and 6. | 3 doses | For people 9 years and older who are immunocompromised or living with HIV, regardless of age. Minimum intervals: 4 weeks between doses 1 and 2, 12 weeks between doses 2 and 3, and 24 weeks between doses 1 and 3. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Can be offered in pregnancy; it is usually deferred until after, and a dose given before pregnancy was known is not a concern.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Human papillomavirus (HPV) vaccines: Canadian Immunization Guide — Chapter revised July 2024
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365